EMD 21657
EMD 21657 is a derivative of Piracetam (HY-B0585) . EMD 21657 inhibits LOT compound action potential, and enhances the local anesthetic effect of Hexanol (HY-W032022) . EMD 21657 exhibits hemolytic effect, and can be used in research about alcoholic encephalopathy syndrome[1].
Product Specifications
CAS Number
[61711-37-3]
UNSPSC
12352005
Target
IGluR
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/emd-21657.html
Smiles
OC1=C(CCNCC)C(CSC)=CN=C1C
Molecular Formula
C12H20N2OS
Molecular Weight
240.37
References & Citations
[1]Richards CD, et al., Degenerate perturbations of protein structure as the mechanism of anaesthetic action. Nature. 1978 Dec 21-28;276 (5690) :775-9.|[2]Saletu B, et al., Treatment of the alcoholic organic brain syndrome with EMD 21657. A derivative of a pyritinolmetabolite: double-blind clinical, quantitative EEG and psychometric studies. Int Pharmacopsychiatry. 1978;13 (3) :177-92.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6481457-01 0.1 mL
IKK epsilon, CT (IKKe, IkappaB Kinase epsilon, IKBKE Protein, IKK iota, IKKi, IKK Related Kinase epsilon, Inducible IkappaB Kinase, Inhibitor of kappa Light Polypeptide Gene Enhancer in B cells Kinase epsilon, Inhibitor of Nuclear Factor kappa B Kinase Su
Ask
View Details 
MBS6481457-02 5x 0.1 mL
IKK epsilon, CT (IKKe, IkappaB Kinase epsilon, IKBKE Protein, IKK iota, IKKi, IKK Related Kinase epsilon, Inducible IkappaB Kinase, Inhibitor of kappa Light Polypeptide Gene Enhancer in B cells Kinase epsilon, Inhibitor of Nuclear Factor kappa B Kinase Su
Ask
View Details 
